Cameco Corporation $CCJ Shares Sold by Plato Investment Management Ltd

Plato Investment Management Ltd lessened its position in shares of Cameco Corporation (NYSE:CCJ) (TSE:CCO) by 30.5% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 14,316 shares of the basic materials company’s stock after selling 6,287 shares during the quarter. Plato Investment Management Ltd’s holdings in Cameco were worth $1,319,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also made changes to their positions in the company. Bison Wealth LLC raised its stake in Cameco by 16.1% during the fourth quarter. Bison Wealth LLC now owns 21,448 shares of the basic materials company’s stock worth $1,102,000 after acquiring an additional 2,975 shares during the period. AQR Capital Management LLC grew its holdings in Cameco by 16.6% during the first quarter. AQR Capital Management LLC now owns 9,547 shares of the basic materials company’s stock worth $393,000 after acquiring an additional 1,361 shares during the period. Integrated Wealth Concepts LLC increased its holdings in shares of Cameco by 48.7% in the first quarter. Integrated Wealth Concepts LLC now owns 8,485 shares of the basic materials company’s stock valued at $349,000 after buying an additional 2,780 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Cameco by 11.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 604,841 shares of the basic materials company’s stock valued at $24,895,000 after buying an additional 64,512 shares in the last quarter. Finally, NewGen Equity Long Short Fund purchased a new stake in shares of Cameco in the second quarter valued at $14,252,000. 70.21% of the stock is currently owned by institutional investors.

Cameco News Summary

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: Scotiabank raised its FY2026 earnings estimate for Cameco to $1.07 per share from $0.89 and maintained an Outperform rating with a $175 price target, signaling continued confidence in the company’s longer-term earnings power.
• Neutral Sentiment: Unusual options activity showed heavy call buying in Cameco, with 384,705 call contracts purchased versus the typical 24,198, suggesting traders are positioning for more upside or volatility.
• Neutral Sentiment: Cameco announced the election of nine board members at its annual meeting, a routine governance update that is unlikely to materially affect fundamentals on its own. Cameco Announces Election of Directors
• Neutral Sentiment: Scotiabank also trimmed its FY2027 earnings estimate to $1.37 from $1.47, which softens the bullish tone a bit, though the firm still sees Cameco as an outperformer.
• Negative Sentiment: Cameco shares were pressured along with other nuclear names after a strong recent rally, as investors took profits following the sector’s explosive run-up. NANO Nuclear Slides 10%, Oklo Falls 8%, Cameco Slips 4% After Nuclear Stocks Explosive Rally

Analyst Ratings Changes

CCJ has been the subject of a number of research reports. Raymond James Financial reissued an “outperform” rating on shares of Cameco in a research note on Wednesday, January 14th. Zacks Research cut Cameco from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 18th. Weiss Ratings lowered shares of Cameco from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday. Canadian Imperial Bank of Commerce boosted their target price on shares of Cameco to $202.00 in a research report on Monday, March 9th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and set a $147.00 price objective on shares of Cameco in a research report on Thursday, February 5th. Eleven equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $153.13.

Cameco Trading Up 0.0%

Shares of CCJ opened at $116.79 on Monday. The stock has a fifty day moving average price of $114.87 and a two-hundred day moving average price of $105.97. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.09 and a current ratio of 3.08. Cameco Corporation has a 52-week low of $48.81 and a 52-week high of $135.24. The company has a market cap of $50.87 billion, a price-to-earnings ratio of 108.14, a PEG ratio of 2.11 and a beta of 1.04.

Cameco (NYSE:CCJ) (TSE:CCO) last issued its quarterly earnings data on Tuesday, May 5th. The basic materials company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.05. Cameco had a net margin of 18.38% and a return on equity of 11.05%. The firm had revenue of $607.49 million for the quarter, compared to analyst estimates of $598.63 million. During the same quarter in the prior year, the firm earned $0.16 EPS. The company’s revenue was up 7.1% on a year-over-year basis. Analysts predict that Cameco Corporation will post 1.22 EPS for the current fiscal year.

About Cameco

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.